Skip to Main Content

Paper Details

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
J Natl Cancer Inst
73
2015
BRCA1, BRCA1 mutation, BRCA1 variant, BRCA2, BRCA2 variant, BRCA2*, BRCA2*c., Breast, Prostate, and Ovarian Cancers, K3326X, K3326X variant, Polymorphic Stop Codon, breast and ovarian cancer, breast and ovarian cancers, breast cancer, breast, ovarian, and prostate cancer, c.9976A>T;, cancer, estrogen, estrogen receptor, estrogen receptor-negative breast cancer, hormone-related cancers, invasive ovarian cancer, ovarian cancer, patients, prostate cancer, rs11571833, serous ovarian cancer

Datasets

Release 1.2